Literature DB >> 22371244

Transplantation: Does anemia correction delay kidney allograft dysfunction?

Edmund Huang, Suphamai Bunnapradist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22371244     DOI： 10.1038/nrneph.2012.39

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  9 in total

1.  Correction of postkidney transplant anemia reduces progression of allograft nephropathy.

Authors:  Gabriel Choukroun; Nassim Kamar; Bertrand Dussol; Isabelle Etienne; Elisabeth Cassuto-Viguier; Olivier Toupance; François Glowacki; Bruno Moulin; Yvon Lebranchu; Guy Touchard; Maïté Jaureguy; Nicolas Pallet; Yannick Le Meur; Lionel Rostaing; Frank Martinez
Journal:  J Am Soc Nephrol       Date:  2011-12-22       Impact factor: 10.121

2.  Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients.

Authors:  S Kuriyama; H Tomonari; H Yoshida; T Hashimoto; Y Kawaguchi; O Sakai
Journal:  Nephron       Date:  1997       Impact factor: 2.847

3.  Assessing glomerular filtration rate by estimation equations in kidney transplant recipients.

Authors:  E D Poggio; X Wang; D M Weinstein; N Issa; V W Dennis; W E Braun; P M Hall
Journal:  Am J Transplant       Date:  2006-01       Impact factor: 8.086

4.  Long-term renal allograft survival in the United States: a critical reappraisal.

Authors:  K E Lamb; S Lodhi; H-U Meier-Kriesche
Journal:  Am J Transplant       Date:  2010-10-25       Impact factor: 8.086

5.  KDIGO clinical practice guideline for the care of kidney transplant recipients.

Authors: 
Journal:  Am J Transplant       Date:  2009-11       Impact factor: 8.086

6.  MDRD equations for estimation of GFR in renal transplant recipients.

Authors:  Uwe Pöge; Thomas Gerhardt; Holger Palmedo; Hans-Ulrich Klehr; Tilman Sauerbruch; Rainer P Woitas
Journal:  Am J Transplant       Date:  2005-06       Impact factor: 8.086

7.  Correction of anemia with epoetin alfa in chronic kidney disease.

Authors:  Ajay K Singh; Lynda Szczech; Kezhen L Tang; Huiman Barnhart; Shelly Sapp; Marsha Wolfson; Donal Reddan
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

8.  Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial.

Authors:  Chariclia Gouva; Petros Nikolopoulos; John P A Ioannidis; Kostas C Siamopoulos
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

9.  A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Authors:  Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto
Journal:  N Engl J Med       Date:  2009-10-30       Impact factor: 91.245
  9 in total
  1 in total

1.  Anemia and low-grade inflammation in pediatric kidney transplant recipients.

Authors:  Jenni Miettinen; Juuso Tainio; Timo Jahnukainen; Mikko Pakarinen; Jouni Lauronen; Hannu Jalanko
Journal:  Pediatr Nephrol       Date:  2016-08-30       Impact factor: 3.714
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.